M 571
Pill imprint M 571 has been identified as Terbinafine hydrochloride 250 mg.
Terbinafine is used in the treatment of tinea corporis; onychomycosis, toenail; cutaneous candidiasis; tinea pedis; tinea capitis (and more), and belongs to the drug class miscellaneous antifungals. There is no proven risk in humans during pregnancy.
Terbinafine 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Terbinafine hydrochloride Images
- Imprint:
-
M 571
- Strength:
- 250 mg
- Color:
- White
- Size:
- 16.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide
croscarmellose sodium
hydroxypropyl cellulose
lactose monohydrate
magnesium stearate
microcrystalline cellulose
- Drug Class:
- Miscellaneous antifungals
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-5710
Advertisement
More Terbinafine Hydrochloride resources
- Terbinafine (Wolters Kluwer)
- Terbinafine Granules (Wolters Kluwer)
- terbinafine (Cerner Multum)
- Terbinex (Micromedex) - Includes Dosage Information
- terbinafine (Micromedex) - Includes Dosage Information
- Terbinafine Hydrochloride (AHFS DI)
- Terbinafine (FDA)
- Terbinex (FDA)
Search Again
